Amgen Inc.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…
Drug Manufacturers - General
US, Thousand Oaks [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 85.72 | 85.25 | 84.42 | 83.10 | 82.08 | 77.96 | 80.49 | 81.90 | 82.19 | 82.73 | 81.35 | 75.77 | 75.16 | 75.66 | 70.02 | |
| Profit Margin | 31.45 | 30.74 | 23.64 | 25.17 | 27.21 | 25.71 | 32.03 | 33.59 | 8.66 | 35.35 | 33.57 | 28.57 | 22.68 | 24.89 | 23.83 | |
| Operating Margin | 37.60 | 36.84 | 27.67 | 32.30 | 31.41 | 30.86 | 39.10 | 42.60 | 43.65 | 43.22 | 41.41 | 22.79 | 23.11 | 20.27 | 28.01 | |
|
EPS Growth
|
19.53 | 6.40 | -15.56 | 37.84 | 20.32 | 0.74 | 34.56 | 12.79 | -73.74 | 368.64 | 2.05 | -4.32 | -16.61 | 17.80 | 3.12 | |
| EPS USD | 453.00 | 482.00 | 407.00 | 561.00 | 675.00 | 680.00 | 915.00 | 1,032.00 | 271.00 | 1,270.00 | 1,296.00 | 1,240.00 | 1,034.00 | 1,218.00 | 1,256.00 | |
| Return on Assets (ROA) | 11.62 | 10.64 | 7.54 | 8.00 | 7.68 | 7.47 | 9.69 | 9.95 | 2.48 | 12.64 | 13.13 | 11.54 | 9.63 | 10.06 | 6.91 | |
| Return on Equity (ROE) | 20.32 | 19.32 | 19.35 | 22.80 | 23.00 | 20.01 | 24.71 | 25.85 | 7.84 | 67.15 | 81.07 | 77.20 | 87.96 | 178.97 | 107.78 | |
| Return on Invested Capital (ROIC) | 14.65 | 12.93 | 9.46 | 10.61 | 10.44 | 10.12 | 12.35 | 12.80 | 3.39 | 19.44 | 20.98 | 12.21 | 13.20 | 11.17 | 9.53 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 26.75 | 30.73 | 43.85 | 48.86 | 48.59 | 44.51 | 44.09 | 44.57 | 44.20 | 51.09 | 50.08 | 52.40 | 54.46 | 59.80 | 66.51 | |
| Debt/Equity | 46.77 | 55.81 | 112.61 | 139.19 | 145.40 | 119.15 | 112.37 | 115.80 | 140.02 | 271.43 | 309.14 | 350.58 | 497.15 | 1,063.78 | 1,036.79 | |
| Debt/EBITDA | 127.01 | 162.11 | 286.55 | 366.14 | 450.50 | 405.41 | 302.13 | 300.83 | 289.35 | 246.72 | 228.89 | 284.41 | 269.28 | 357.82 | 362.60 | |
|
Debt/Capitalization
|
31.87 | 35.82 | 52.96 | 58.19 | 59.25 | 54.37 | 52.91 | 53.66 | 58.34 | 73.08 | 75.56 | 77.81 | 83.25 | 91.41 | 91.20 | |
| Long-Term Debt/Capitalization | 31.87 | 31.23 | 52.87 | 55.77 | 57.28 | 53.96 | 51.07 | 50.26 | 57.53 | 70.25 | 73.59 | 77.76 | 83.22 | 91.07 | 91.02 | |
| Interest Debt per Share USD | 11.00 | 14.55 | 24.35 | 35.59 | 44.02 | 41.88 | 43.08 | 47.94 | 50.13 | 53.44 | 51.56 | 58.44 | 60.54 | 75.00 | 126.15 | |
| Debt Growth | 4.18 | 26.05 | 60.37 | 23.81 | 21.11 | -4.40 | 2.74 | 9.63 | 2.16 | -4.00 | -11.87 | 10.31 | 0.98 | 16.92 | 65.91 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 488.82 | 352.04 | 479.54 | 385.15 | 344.37 | 495.33 | 444.42 | 410.66 | 548.51 | 278.90 | 143.67 | 181.45 | 159.10 | 141.43 | 164.92 | |
| Quick Ratio | 401.52 | 300.72 | 409.05 | 328.01 | 278.07 | 421.97 | 396.64 | 368.17 | 497.95 | 243.80 | 101.04 | 130.20 | 106.14 | 94.78 | 162.19 | |
| Cash Ratio | 74.46 | 50.03 | 120.72 | 40.19 | 47.88 | 53.24 | 47.81 | 28.93 | 42.13 | 51.49 | 47.04 | 53.77 | 65.57 | 48.63 | 59.50 | |
| Operating Cash Flow Ratio | 100 | - - | - - | - - | - - | 100 | 100 | - - | 100 | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 94.19 | 109.79 | 97.71 | 106.34 | 110.83 | 167.06 | 173.59 | 151.62 | 143.58 | 139.49 | 121.54 | 158.21 | 157.95 | 129.94 | 88.79 | |
| Receivables Turnover | 694.26 | 644.67 | 538.05 | 685.66 | 692.47 | 788.02 | 723.27 | 726.41 | 705.87 | 663.32 | 575.84 | 561.86 | 530.73 | 473.18 | 354.95 | |
| Payables Turnover | 364.29 | 310.06 | 378.04 | 322.43 | 425.16 | 364.85 | 438.03 | 453.87 | 300.96 | 339.77 | 317.72 | 433.43 | 472.47 | 407.51 | 531.51 | |
|
Asset Turnover
|
36.95 | 34.62 | 31.88 | 31.80 | 28.24 | 29.07 | 30.26 | 29.62 | 28.58 | 35.75 | 39.13 | 40.39 | 42.47 | 40.42 | 29.02 | |
| Fixed Turnover | 255.18 | 272.60 | 287.49 | 324.16 | 349.15 | 384.13 | 441.45 | 463.43 | 457.99 | 478.96 | 474.07 | 520.02 | 501.14 | 485.04 | 474.50 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 952.60 | 918.05 | 706.89 | 529.63 | 574.07 | 578.06 | 773.52 | 777.30 | 764.80 | 737.28 | 750.50 | 459.11 | 501.67 | 379.45 | 274.68 | |
| Asset Coverage | 300 | 200 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | - - | - - | |
| Cash Flow Coverage (CFGR) | 59.77 | 43.31 | 23.89 | 22.17 | 19.58 | 27.85 | 28.76 | 29.93 | 31.63 | 33.29 | 30.60 | 31.82 | 27.80 | 24.96 | 13.11 | |
| EBITDA Coverage | 1,000 | 1,000 | 800 | 600 | 600 | 600 | 800 | 800 | 800 | 700 | 800 | 700 | 700 | 600 | 500 | |
| Dividend Coverage | - - | - - | -700 | -300 | -300 | -200 | -200 | -200 | - - | -200 | -200 | -100 | -100 | -100 | -100 | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 200 | 200 | 200 | 200 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | 0.86 | 1.67 | 1.65 | 1.53 | 1.95 | 2.74 | 2.65 | 2.73 | 2.41 | 2.79 | 3.13 | 2.97 | 2.96 | |
| Earnings Yield | 8.01 | 8.78 | 6.34 | 6.50 | 5.92 | 4.27 | 5.64 | 7.06 | 1.56 | 6.52 | 5.38 | 5.39 | 4.60 | 4.64 | 4.36 | |
|
Price/Earnings (P/E)
|
1,248.10 | 1,139.05 | 1,577.79 | 1,537.51 | 1,690.66 | 2,343.95 | 1,773.25 | 1,416.28 | 6,423.49 | 1,532.96 | 1,859.82 | 1,854.81 | 2,176.02 | 2,156.60 | 2,294.04 | |
| Price/Earnings Growth (PEG) | 63.92 | 177.93 | -101.40 | 40.63 | 83.20 | 3,164.34 | 51.31 | 110.76 | -87.11 | 4.16 | 908.45 | -429.26 | -130.98 | 121.19 | 735.30 | |
|
Price/Book (P/B)
|
253.56 | 220.11 | 305.38 | 350.50 | 388.77 | 469.01 | 438.15 | 366.08 | 503.63 | 1,029.41 | 1,507.78 | 1,431.96 | 1,913.92 | 3,859.61 | 2,472.57 | |
| Price/Tangible Book (P/TB) | 253.56 | 220.11 | 305.38 | 350.50 | 388.77 | 469.01 | 438.15 | 366.08 | 503.63 | 1,029.41 | 1,507.78 | 1,431.96 | 1,913.92 | 3,859.61 | 2,472.57 | |
| Price/Sales (P/S) | 392.54 | 350.12 | 372.93 | 386.94 | 459.96 | 602.61 | 568.03 | 475.69 | 556.35 | 541.87 | 624.29 | 529.94 | 493.60 | 536.79 | 546.61 | |
|
Price/Cash Flow (P/CF)
|
907.12 | 910.73 | 1,135.18 | 1,135.75 | 1,365.48 | 1,413.22 | 1,355.58 | 1,056.26 | 1,137.34 | 1,139.14 | 1,593.96 | 1,283.54 | 1,384.66 | 1,453.56 | 1,819.04 | |
| Price/Free CF (P/FCF) | 989.93 | 1,012.18 | 1,276.58 | 1,286.44 | 1,534.52 | 1,600.92 | 1,459.97 | 1,149.15 | 1,209.18 | 1,218.76 | 1,709.42 | 1,362.45 | 1,530.04 | 1,608.43 | 2,093.91 | |
| Price/Operating CF (P/OCF) | 907.12 | 910.73 | 1,135.18 | 1,135.75 | 1,365.48 | 1,413.22 | 1,355.58 | 1,056.26 | 1,137.34 | 1,139.14 | 1,593.96 | 1,283.54 | 1,384.66 | 1,453.56 | 1,819.04 |